Abstract: Apoptosis is implicated in unfavorable remodeling of the left ventricle during acute myocardial infarction (AMI). Both DNA damage and p53 play important roles in regulating apoptosis. Expression patterns of apoptotic regulating genes such as p53, bax, and bcl-2 highlight the importance of inhibiting ventricle remodeling and subsequent injuries. In the present study, serum levels of p53 and 8-hydroxy-2-deoxyguanosine (8-OHdG) as well as p53, bax, and bcl-2 expression were examined after the onset of AMI in Iranian patients. Serum levels of p53 and 8-OHdG were measured by enzyme-linked immunosorbent assay (ELISA) and the presence of p53 protein and mRNA expression of p53, bax, and bcl-2 were analyzed by Western blotting and real time RT-PCR methods respectively. In patients presenting with AMI, serum levels of p53 and 8-OHdG were increased in comparison to healthy controls. Likewise, transcripts of p53 and bax were also elevated in patients while bcl-2 was decreased. Collectively, our data suggest the novel use of p53 and 8-OHdG as markers of apoptosis and DNA damage following AMI. Our results also revealed that apoptosis occurs in concert with an up-regulation of p53 and bax and a down-regulation of bcl-2 which may suggest a possible therapeutic intervention in patients recovering from AMI.
Introduction
Myocardial infarction (MI) is one of the most frequent cardiovascular events in the world. Apoptosis is a physiological and pathological event associated with cardiomyocyte cell death during MI and heart failure [1, 2] . Apoptosis during the acute and chronic myocardial infarction has been demonstrated in human and animal studies [3] [4] [5] . Apoptosis can be induced by DNA damage and p53 up-regulation [6] which is affected by oxidative stress. Oxidative stress due to reactive oxygen species (ROS) takes part in oxygen toxicity causing damage to cellular and subcellular organelles such as the cellular membrane [7, 8] and mitochondria [9] or sarcoplasmic reticulum [10] in cardiac myocytes. This damage is mediated by the oxidation of proteins and lipids through the modification of genomic and cellular structures [11] . Therefore, ROS impairs cardiac function and is recognized as an important factor contributing to heart failure [12] [13] [14] [15] [16] [17] [18] [19] [20] . DNA is one of the major targets of ROS, and an increase in DNA damage results in the mutation of genes that regulate cell growth. DNA damage also induces the expression of the transcription factor p53 that is responsible for the regulation of the cellular response to damage. Protein levels of p53 increase in response to DNA damage [21] and oxidative stress [22] .
The most reliable serum markers of apoptosis and oxidative DNA damage are p53 and 8-OHdG respectively [23, 24] . Evidence of apoptosis is provided by p53-stimulated transcription of the proapoptotic bax gene [25] [26] [27] , and repression of the antiapoptotic bcl-2 gene [25] [26] [27] [28] . Monitoring such factors may play a significant role in designing new therapeutic strategies to inhibit apoptosis often associated with AMI and lead to productive healing. In this regard, we proposed to measure p53 and 8-OHdG levels as markers of apoptosis and DNA damage respectively in the serum of Iranian patients with AMI, and to examine transcript levels of p53, bax, and bcl-2 in PBMCs.
Experimental Procedures

Study Design
The study subjects consisted of 50 consecutive patients with AMI (38 males; age, 56.8±1.8 years; range, 33-78 and 12 females; age, 59.5±2.8 years; range, . Of the 59 patients screened, 54 subjects were subsequently enrolled. Three patients refused enrollment in the study and two patients was excluded for lack of demographic data. Four patients had inappropriate processing of initial laboratory specimens and were subsequently excluded from further study. All patients were included in initial data analysis for presentation and immediate peri-procedural assessment. We also studied 50 normal volunteers as control subjects (25 
Blood collection and isolation of peripheral blood mononuclear cells (PBMCs)
Twenty milliliters of peripheral blood was collected from healthy donors and patients presenting with AMI within the first 24-48 hours after the onset of symptoms for measurement of serum levels of p53 and 8-OHdG. Serum was obtained from peripheral blood (5 ml) by centrifugation and stored at -85°C until the assay. PBMCs were prepared from buffy coats by using Lymphoprep (Axis-Shield PoC AS, Oslo, Norway) for real time RT-PCR and Western blotting analysis.
p53 and 8-OHdG measurement by ELISA analysis
Serum levels of p53 and 8-OHdG were measured in the patients and healthy individuals with competitive ELISA kits from Bender MedSystems (Burlingame, CA, USA) [23] and GENTAUR (8-OHdG Check; Japan Institute for the Control of Aging, Fukuroi, Shizuoka, Japan) [29] respectively. Measurement was performed according to the manufacturer's instructions.
Quantitative real-time RT-PCR assay
RNA was extracted from PBMCs using GenElute 30 min at 60°C, 10 min at 95°C, and then 45 cycles of amplification for 15 s at 95°C and 1 min at 55°C followed by terminal elongation for 10 min at 72°C. The primer set and probe for bcl-2 were 5'-TTG GCC CCC GTT GCT T-3' (forward), 5'-CGG TTA TCG TAC CCC GTT CTC-3' (reverse), and 5'-AGC GTG CGC CAT CTT TCC CAG-3' (probe). The bax primer and probe sequences were 5'-TGG AGC TGC AGA GGA TGA TTG-3' (forward), 5'-GAA GTT GCC GTC AGA AAA CAT G-3' (reverse), and 5'-ACA TAC TAA ATT GGA GCA CTC TGT GTG-3' (probe). Primer and probe sequences were obtained from previously published sequences [30, 31] . The PCR conditions consisted of 50°C for 2 min followed by 95°C for 10 min, then 50 cycles of 95°C for 15 s and 60°C for 1 min. Each sample was amplified in triplicate and adequate negative controls were included in each PCR run. The specificity of the PCR was verified by melting curve analysis and subsequently, by agarose gel electrophoresis.
Endogenous controls for target gene expression evaluation
The most commonly used housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used in this study. The sequences of the primers were as follows: 5'-GAA GGT GAA GGT CGG AGT C-3' (forward), 5'-GAA GAT GGT GAT GGG ATT TC-3' (reverse), and 5'-CCG ACT CTT GCC CTT CGA AC-3' (probe). Primer and probe sequences were obtained from previously published sequences [30] . The probes were labeled with the 5' 6-carboxy-fluorescein (FAM) reporter dye and the 3' 6-carboxytetramethylrhodamine (TAMRA) quencher dye. The control gene was amplified in triplicate under PCR conditions applied for the amplification of the target genes.
p53 Detection by Western blotting analysis
SDS-PAGE was performed by the method of Laemmli [32] and the Western blotting procedure of Towbin [33] .
PBMCs were lysed with lysis buffer containing 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM PMSF (Phenyl methyl sulfonyl fluoride), 10 mg/ml of leupeptin, 10 mg/ml of aprotinin, 2 mM Na 3 VO 4 , and 10 mM NaF (all purchased from Sigma). The protein lysates were resolved with a 10% polyacrylamide gel and transferred to a nitrocellulose membrane (Sigma) and blocked with PBS containing 2% BSA. The membrane was incubated in a 1% BSA solution containing 1:500 dilution of primary antibody (mouse monoclonal anti-p53, Santa Cruz Biotechnology, Inc. CA. USA) for 90 min at room temperature (RT) with gentle shaking. After washing, bound antibodies were detected by 1:1000 goat anti mouse immunoglobulin-HRP conjugate (Dako) for 90 min at RT. Then, 3,3-diaminoobenzidinetetrahydrochloride solution (DAB, Roche) was added and incubated for 10 min for band detecting.
Statistical Analysis
All data are expressed as a mean ± SEM. Statistical analysis of the data was carried out by SPSS, version 16, statistical software program and Student's t test when comparing 2 groups. A P value less than 0.001 was considered significant.
Results
Demographic characterization
We studied 50 patients with AMI admitted to the Shahid Modarress Hospital and 50 control subjects. Table 1 shows the admission demographic features of the study population.
Serum levels of p53 and 8-OHdG in patients with AMI
p53 and 8-OHdG were measured by ELISA which serum levels of p53 and 8-OHdG were higher in the patients compared with control subjects ( 
Analysis of expression of p53, bax, and bcl-2 transcripts and presence of p53 protein
The level of p53 mRNA was assessed by performing real time RT-PCR on samples prepared from patients with AMI and control subjects. In the PBMCs from patients with AMI, transcript levels of p53 and bax were 4.5-fold and 3-fold higher than samples from healthy individuals. In contrast, bcl-2 expression in PBMCs from AMI patients is decreased to approximately 0.75-fold in comparison to that observed in control samples ( Figure 1 ). Western blotting analysis of PBMC lysates was performed for the detection of p53. Cell extracts from patients and control subjects contained 53 kDa bands (Figure 2 ).
Discussion
Three important findings were obtained in this study. First of all, the levels of circulating p53 and its mRNA expression were increased in patients with AMI when compared to controls. Secondly, the serum level of 8-OHdG was elevated in the serum of the patients with AMI. Thirdly, we also showed an up-regulation of bax and down-regulation of bcl-2 in patients with AMI. Our observations suggest that an inhibitory strategy to block overexpression of p53 and its directly affected bax and bcl-2 genes may be an important therapeutic approach to arrest apoptosis during the recovery of AMI.
Previous studies have reported the presence of apoptosis in most cases of AMI [34] [35] [36] [37] . These studies demonstrated that during an AMI widespread apoptosis occurs and is evident only a few hours after the onset of AMI, prior to the appearance of necrosis [35] . In addition, apoptosis was not detected in the normal myocardium [35, 38, 39] . Previous studies also suggest the possibility that an increased apoptotic rate in AMI influences peripheral circulation. Consistent with the previous reports of apoptosis occurring in infarcted cardiac tissue, we observed elevated levels of p53 in the serum of AMI patients. Serum levels of p53 may provide a reliable marker for AMI which can be used in the development of new therapeutic approaches designed to arrest apoptosis and consequent tissue damage during recovery from AMI.
Evidence from human studies as well as in vitro and animal models show that cardiac myocyte apoptosis can be induced by a variety of stimuli and in a number of disease states, including MI [40] [41] [42] and heart failure [42] [43] [44] [45] . Injury in MI and stroke occurs in the infarcted area as adjacent cells undergo apoptosis [6] . In this way, cell damage induces p53 expression which in turn regulates the transcription of a number of apoptotic genes. The p53 protein, is normally present in the cytosol at low concentrations but is increased in response to a number of apoptotic-inducing stimuli, including oxidative stress [22] and DNA damage [21, [46] [47] [48] [49] . Direct measurement of ROS is difficult because of its lower serum levels and shorter half-life. However, measurement of oxidative byproducts is more feasible. Therefore in present study, we investigated 8-OHdG which is one of the most abundant oxidative DNA products and a sensitive DNA damage marker and found increased oxidative DNA damage in the serum of patients with AMI, so oxidative stress is also a condition under which DNA damage occurs. In agreement with previous studies, our results showed an increase in p53 and 8-OHdG in the circulation [23, 24] . Furthermore, the bcl-2 gene family is a complex network regulating apoptosis which some of the candidates can suppress apoptosis while the others can induce it [50] . Apoptosis initiated by various different stimuli can be blocked by bcl-2 overexpression. An increase in expression and activity of p53 can increase the transcription of the bax while suppressing transcription of bcl-2 [27, 28] . In this study, we confirmed an increase in expression of bax with a coordinate reduction in the transcription of bcl-2. These observations are particularly intriguing in light of the fact that these regulating factors are important in apoptosis and play an important role in cardiac function in heart failure [51, 52] .
